NBC Johnson & Johnson Takes Big Step Forward With Its Vaccine Trial, Has Potential to Be Single Shot
Unlike Pfizer and Moderna, Johnson & Johnson’s COVID-19 vaccine could potentially only require a single dose. Read Article
Nat GeoShould people take more than one type of COVID-19 vaccine?
All these authorizations foretell a world with vaccine choice. Here’s what research says about whether more is better for boosting your immunity. Read Article
NYTHow the Johnson & Johnson Vaccine Works
The Johnson & Johnson vaccine is based on the virus’s genetic instructions for building the spike protein. But unlike the Pfizer-BioNTech and Moderna vaccines, which store the instructions in single-stranded RNA, the Johnson & Johnson vaccine uses double-stranded DNA. Read Article
Nature
Immune Response In Animals Good News For COVID-19 Vaccine Development
News today from Harvard’s Center for Virology and Vaccine Research may help solve a problem that future COVID-19 manufacturers are sure to face: how to make sure that new and potentially better vaccines actually work without doing extremely large and expensive studies. Read more
BIDMC researchers define immune system’s requirements for protection against COVID-19
Findings are important for vaccines, therapeutics and public health strategies to combat the COVID-19 pandemic. Read here
ABCNEWSResearchers hunt for clues in our blood to discover COVID-19 vaccines of the future
Approval of early vaccines will make researching future ones very difficult. Read article
Could a Blood Test Show if a Covid-19 Vaccine Works?
A new monkey study offers a ray of hope for speeding up clinical trials of Covid-19 vaccines. Read Article
A blood test showing the effectiveness of a vaccine on monkeys has the potential to speed up trials
A new study in monkeys suggests that a blood test could predict the effectiveness of a coronavirus vaccine — and perhaps speed up the clinical trials needed to get a working vaccine to billions of people around the world. Read Article
The Scientists Leading the Coronavirus Vaccine Race
Our very own, Dr. Barouch, was selected as part of the Bloomberg 50. Read here
